Advanced strategies to enhance the safety, persistence, and efficacy of CAR-T cells in solid tumors - Top-Institutions - MDSpire

Advanced strategies to enhance the safety, persistence, and efficacy of CAR-T cells in solid tumors

  • By

  • Iqra Ajmal

  • Bingtan Du

  • Na Huang

  • Qianying Huang

  • Dan Jiang

  • Muhammad Asad Farooq

  • Guangxian Xu

  • May 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology-Oncology

  • #3

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Hematology-Oncology

  • #4

    Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital Cancer Center

    Boston, MA

    Key Differentiators

    • Hematology-Oncology

Original Source(s)

Advanced strategies to enhance the safety, persistence, and efficacy of CAR-T cells in solid tumors

  • by Iqra Ajmal, Bingtan Du, Na Huang, Qianying Huang, Dan Jiang, Muhammad Asad Farooq, Guangxian Xu

  • May 20, 2026

Related Content

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease